JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by THOENEN, H.
Right arrow Articles by HUERLIMANN, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by THOENEN, H.
Right arrow Articles by HUERLIMANN, A.
Journal of Pharmacology And Experimental Therapeutics, Vol. 162, Issue 1, 70-79, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


FORMATION OF A "FALSE" ADRENERGIC TRANSMITTER IN CATS PRETREATED WITH 4-METHOXY- 3,5-DIHY-DROXYPHENYLALANINE AND ITS EFFECTS ON POSTGANGLIONIC SYMPA-THETIC TRANSMISSION

H. THOENEN 1, W. HAEFELY 1, G. HAEUSLER 1, and A. HUERLIMANN 1

1 Department of Experimental Medicine, F. Hoffmann-La Roche & Co. Ltd., Basle, Switzerland

Pretreatment of cats with (50 mg/kg p.o. 28, 20 and 4 hr before sacrifice) 4-methoxy- 3,5-dihydroxyphenylalanine resulted in a marked depletion of norepinephrine in sympathetically innervated organs (heart, 8.3%; spleen, 7.2%; iris, 17.3%; and nictitating membrane, 19.2% of controls). The response to sympathetic nerve stimulation was diminished in the heart, the nictitating membrane and the isolated perfused spleen in which both contractile response and norepinephrine output was greatly reduced. The effect of i.v. injected norepinephrine on blood pressure and nictitating membrane did not differ significantly from that on untreated controls. The chromatographic analysis of the amines present in spleen and heart after administration of 4-methoxy-3,5-dihydroxyphenylalanine revealed the accumulation of 4-methoxy-3,5-dihydroxyphenethylamine, which was liberated as a false transmitter by sympathetic nerve stimulation. The expected beta-hydroxylated metabolite of 4-methoxy-3,5-dihydroxyphenethylamine could be detected neither after pretreatment with 4-methoxy-3,5-dihydroxyphenylalanine nor after injection of H3-4-methoxy-3,5- dihydroxyphenethylamine. It is concluded that the diminished response to sympathetic nerve stimulation results from a reduction of the physiologic transmitter norepinephrine available for liberation and its replacement by a less potent "false" transmitter substance.

Submitted on December 20, 1967
Accepted on March 7, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.